The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
23 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $13,319,150 in first-year total cost, median $617,907.
Most frequent study sections
- Special Emphasis Panel[ZRG1 SBIB-Q (58)]12
- Special Emphasis Panel[ZRG1 SBIB-Z (58)]7
- Special Emphasis Panel[ZRG1 SBIB-F (58)]4
Most frequent institutions
- SLOAN-KETTERING INST CAN RESEARCH3
- STANFORD UNIVERSITY3
- JOHNS HOPKINS UNIVERSITY2
- UNIVERSITY OF WASHINGTON2
- CEDARS-SINAI MEDICAL CENTER1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2018 | PET nanoreporter image-guided breast cancer therapy1R01CA220234-01A1 | MULDER, WILLEMPÉREZ-MEDINA, CARLOSREINER, THOMAS | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $758,800 | ZRG1 |
| 2018 | Ultrasound-guided DNA delivery for regenerative medicine1R01EB026094-01 | GAZIT, DAN | CEDARS-SINAI MEDICAL CENTER, CA | $697,429 | ZRG1 |
| 2018 | Treating Tumoral Hypoxia via Ultrasound-Guided Oxygen Release for Improving Radiation Therapy1R01CA232148-01 | DAYTON, PAUL A | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $676,220 | ZRG1 |
| 2018 | Quantitative control of CAR T cells via image-guided delivery and monitoring1R01EB026892-01 | FARWELL, MICHAEL DAVIDPOWELL, DANIEL J. | UNIVERSITY OF PENNSYLVANIA, PA | $651,868 | ZRG1 |
| 2018 | The Impact of FUS-Mediated Brain Cancer Therapy on BBB Transport, Cytokines, and Immunocyte Trafficking1R01CA227687-01 | BUTTS-PAULY, KIM | STANFORD UNIVERSITY, CA | $639,521 | ZRG1 |
| 2018 | Clinically Translatable Ultrasound-Sensitive Microbubble Approaches for Overcoming Tumor Hypoxia1R01EB026881-01 | EISENBREY, JOHNWHEATLEY, MARGARET A. | THOMAS JEFFERSON UNIVERSITY, PA | $634,686 | ZRG1 |
| 2018 | Image-guided TRAIL-enhanced CAR T-cell immunotherapy1R01CA220524-01A1 | PONOMAREV, VLADIMIR | SLOAN-KETTERING INST CAN RESEARCH, NY | $625,160 | ZRG1 |
| 2018 | Delineating Functional Immunity via Image-Guided PET1R37CA220482-01A1 | GIBSON, HEATHER MARIEVIOLA, NERISSA THERESE | WAYNE STATE UNIVERSITY, MI | $566,226 | ZRG1 |
| 2018 | Controllable In Vivo Genome Editing for Immune-Checkpoint Blockade in Solid Tumors1R01EB026893-01A1 | TONG, SHENG | RICE UNIVERSITY, TX | $533,472 | ZRG1 |
| 2018 | Non-invasive Quantification of Dose-Exposure-Response of PD-L1 Therapeutics at the Tumor1R01CA236616-01 | NIMMAGADDA, SRIDHAR | JOHNS HOPKINS UNIVERSITY, MD | $520,780 | ZRG1 |
| 2018 | Iron oxide nanotheranostics for breast cancer1R01EB026890-01 | ZHANG, MIQIN | UNIVERSITY OF WASHINGTON, WA | $465,597 | ZRG1 |
| 2018 | Image-guided irreversible electroporation directed CAR T-cell delivery to solid tumors1R01CA236615-01 | ADUSUMILLI, PRASAD S.SOLOMON, STEPHEN BARNETTSRIMATHVEERAVALLI, GOVINDARAJAN | SLOAN-KETTERING INST CAN RESEARCH, NY | $392,764 | ZRG1 |
| 2017 | Smart and self-reporting clinical nano carriers for drug delivery1R01CA215700-01 | GRIMM, JAN | SLOAN-KETTERING INST CAN RESEARCH, NY | $713,953 | ZRG1 |
| 2017 | Image-Guided Drug Delivery for Pancreatic Neuroendocrine Tumor.1R01EB022230-01A1 | CHOI, HAK SOOHENARY, MAGED M | MASSACHUSETTS GENERAL HOSPITAL, MA | $676,225 | ZRG1 |
| 2017 | MR-Guided Focused Ultrasound Combined with Immunotherapy to Treat Malignant Brain Tumors1R01CA217953-01 | WINTERMARK, MAX | STANFORD UNIVERSITY, CA | $652,022 | ZRG1 |
| 2017 | Targeting Neuroendocrine Prostate Cancer Using Multi-Probe Hyperpolarized 13C MRI for Improved Treatment and Therapeutic Monitoring1R01CA215694-01A1 | AGGARWAL, RAHULKURHANEWICZ, JOHN | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $650,042 | ZRG1 |
| 2017 | Therapeutic miRNA Modulation of Hepatocellular Carcinoma Using Ultrasound Guided Drug Delivery1R01CA209888-01A1 | DAHL, JEREMYPAULMURUGAN, RAMASAMY | STANFORD UNIVERSITY, CA | $617,907 | ZRG1 |
| 2017 | Ultrasound-triggered red blood cell drug delivery with photoacoustic tracking1R01EB023055-01A1 | KLIBANOV, ALEXANDER L | UNIVERSITY OF VIRGINIA, VA | $563,764 | ZRG1 |
| 2017 | Organic nanoparticles for dual MRI-guided therapeutic selection and ovarian cancer drug delivery1R01CA220468-01 | JOHNSON, JEREMIAH ALLEN | MASSACHUSETTS INSTITUTE OF TECHNOLOGY, MA | $538,985 | ZRG1 |
| 2017 | Ultrasound-enhanced drug penetration for treatment of pancreatic cancer2R01CA154451-04A1 | HWANG, JOO HA | UNIVERSITY OF WASHINGTON, WA | $498,703 | ZRG1 |
| 2017 | Tumor-targeted nanoparticle-based delivery system for imaging and treatment of cancer1R01CA209818-01A1 | MINKO, TAMARA | RUTGERS, THE STATE UNIV OF N.J., NJ | $470,010 | ZRG1 |
| 2017 | HER2-pretargeting image-guided therapy of breast cancer1R01CA209884-01A1 | ARTEMOV, DMITRI | JOHNS HOPKINS UNIVERSITY, MD | $404,441 | ZRG1 |
| 2017 | Image Guided Delivery and Evaluation of Low? Density Lipoprotein-Docosahexaenoic acid Nanoparticles for the Management of Hepatocellular Carcinoma1R01CA215702-01A1 | CORBIN, IAN RONALD | UT SOUTHWESTERN MEDICAL CENTER, TX | $370,575 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.